StockNews.AI
YMAB
StockNews.AI
14 days

Shareholder Alert: The Ademi Firm investigates whether Y-mAbs Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

1. Y-mAbs is under investigation for fiduciary duty breaches related to a deal. 2. Shareholders will receive $8.60 per share, totaling $412 million in equity. 3. Insiders benefit substantially from change of control arrangements. 4. The deal restricts competing bids with significant penalties. 5. Investigation questions the board's commitment to all shareholders.

4m saved
Insight
Article

FAQ

Why Bearish?

The investigation raises concerns about corporate governance, affecting investor confidence. Historical cases show similar investigations negatively impacted stock prices.

How important is it?

Ongoing investigations signal potential risks and lower investor trust, impacting stock value.

Why Short Term?

Market reaction to investigation news typically occurs quickly, affecting the stock's price soon after.

Related Companies

SERB
, /PRNewswire/ -- The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for possible breaches of fiduciary duty and other violations of law in its transaction with SERB Pharmaceuticals. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.  There is no cost or obligation to you. In the tender offer transaction, shareholders of Y-mAbs will receive $ $8.60 per share in cash, representing approximately $412 million in equity value. Y-mAbs insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Y-mAbs by imposing a significant penalty if Y-mAbs accepts a competing bid. We are investigating the conduct of the Y-mAbs board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts Ademi & Fruchter LLP                                  Guri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001 SOURCE Ademi LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News